Stirling signs agreement with North American bioscience company
01 February, 2007 -
Stirling Products, an Australian public company, announced today that it has signed an agreement for the co-development of Stirling’s R-salbutamol products within North America as well as registration and distribution of PBI’s natural immune stimulant (ProVale™) in Australia and Pacific Rim countries.
Asia is a large producer of shrimp and, according to Stirling Products, the effects of ProVale™ on shrimp production by controlling disease states in commercial shrimp farms are impressive.
The agreement details a series of steps that both parties will undertake within the next 180 days to evaluate the potential for a merger of common interests, intellectual property, know-how and operations.
"The relationship has considerable benefits for Stirling," indicated CEO and Managing Director, Dr. Calvin London. "ProVale™ has been demonstrated to be an effective yet natural alternative for growth promotional properties of antibiotics in swine and poultry. This natural 'immunobiotic' has the benefit of boosting the immune system by significantly increasing the immunity to both viral and bacterial diseases in swine (i.e. sows, piglets and finisher pigs), poultry (i.e. broilers and turkeys) and farmed aquaculture species (i.e. shrimp) and fish.
"Provale™ is a highly purified, safe and natural immune stimulating bioactive extract for use as a livestock or pet animal feed supplement. This unique "immunobiotic" has the benefit of boosting the immune system by increasing the immunity to various bacterial and viral diseases of animals. The product already has sales in North America and expects to increase sales in South East Asia before the end of the year."
www.fishfarmer-magazine.com is published by Special Publications. Special Publications also publishes FISHupdate.com, FISHupdate magazine, Fish Farmer, the Fish Industry Yearbook, the Scottish Seafood Processors Federation Diary, the Fish Farmer Handbook and a range of wallplanners.
Printer friendly version
Email this article to a friend
Related articles:
|